Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

Rosetta Genomics (NASDAQ: ROSG) is Profiled in this Database

Updated At 05 Mar, 2009

Start Free 7 Day Trial Now
Partial description of this company
Molecular diagnostic tests to: 1-Differentiate between squamous and non-squamous non-small-cell lung cancer, 2-Differentiate between mesothelioma and adenocarcinoma, 3-Identify more than 20 types of cancer

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Rosetta Genomics (NASDAQ: ROSG) plus 4982 other startups.

Start Free 7 Day Trial Now

Learn More About Rosetta Genomics (NASDAQ: ROSG)

Technology/product details

CEO presentation


Our Clients